Brain Cancer Clinical Trials

Showing 1221-1240 of 1,466 trials

Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue

NCT00723463

The purpose of this study is to determine normal measurements (ADC values) from the head and neck of healthy volunteers using 3T MRI.

Brain CancerNeck Cancer

University of Michigan200 participantsStarted Jun 2006

Ann Arbor, Michigan, United States

COMPLETEDPhase 1

A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

NCT01547546

This open-label, multicenter, Phase I, dose-escalating study will evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics and efficacy of GDC-0084 in patients with progressive or recurrent high-grade glioma. Stage 1 is the dose escalation part of the study. Stage 2, patients will receive GDC-0084 at a recommended dose for future studies.

Glioblastoma, Glioma

Genentech, Inc.29 participantsStarted Apr 2012

Los Angeles, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

TERMINATEDPhase 2

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

NCT01113463

The goal of this clinical research study is to learn if TPI 287 can help to control glioblastoma. The safety of this drug will also be studied.

Brain Cancer

M.D. Anderson Cancer Center17 participantsStarted Apr 2010

Houston, Texas, United States

UNKNOWNPhase 1/2

Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study

NCT02939378

Recently, ketogenic diet has been recognized a useful treatment strategy for glioblastoma in vitro. Therefore, the purpose of the study is to evaluate the safety and efficacy of ketogenic adjuvant to salvage chemotherapy for recurrent glioblastoma.

Glioblastoma Multiforme

Song Lin60 participantsStarted Oct 2016

Beijing, Beijing Municipality, China

Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue

A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study

Related Searches

Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme

INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study

Perioperative Evaluation of Intracranial Hypertension by Ultrasound Measurement of Variations in the Diameter of the Sheath of the Optic Nerve in the Excision of a Tumor or Biopsy Supratentorial Brain

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors

Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status

Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Bosutinib in Adult Patients With Recurrent Glioblastoma

Comparative 2-D Tumor Analysis in Familial Gliomas

Comparison of Dexmedetomidine and Propofol-Remifentanil Conscious Sedation for Awake Craniotomy for Tumor Surgery

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Expanded Access to ANG1005 for Individual Patients

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients

Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery